Current treatment of gastrointestinal stromal tumours V. Tzekova Editorial 18 June 2010 Pages: 47 - 48
Imatinib mesylate in the management of gastrointestinal stromal tumours (GIST) G. P. KurtevaP. F. Kurtev Short review 18 June 2010 Pages: 49 - 52
Pathology of gastrointestinal stromal tumours with accent to prognostic criteria M. Kamenova Short review 18 June 2010 Pages: 53 - 57
Adjuvant therapy with imatinib in GIST patients after radical surgery K. D. Koynov Short review 18 June 2010 Pages: 58 - 60
Second-line targeted therapy of gastrointestinal stromal tumours C. Timcheva Short review 18 June 2010 Pages: 61 - 64
Chronic lymphocytic leukaemia – emerging treatment options: a report from the ASH Meeting 2009 N. ZojerH. Ludwig ASH report 18 June 2010 Pages: 65 - 68
Short review – Management of Immune Thrombocytopenia in adults L. WeissR. Greil Short review 18 June 2010 Pages: 69 - 72
Recent developments in the treatment of peripheral T-cell lymphoma G. HopfingerN. WeitM. Herling Short review 18 June 2010 Pages: 73 - 76
Insulin-like growth factor type I receptor: a new target in the treatment of non-small cell lung cancer patients G. HellerS. Zöchbauer-Müller Short review 18 June 2010 Pages: 81 - 84
Head and neck cancer: a step forward S. JelicI. PopovG. M. Sprinzl Short review 18 June 2010 Pages: 85 - 89